I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 6 studies | 20% ± 3% | |
| basal cell | 5 studies | 23% ± 9% | |
| epithelial cell of proximal tubule | 4 studies | 20% ± 5% | |
| epithelial cell | 4 studies | 35% ± 18% | |
| natural killer cell | 3 studies | 20% ± 4% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 20% ± 4% | |
| CD8-positive, alpha-beta T cell | 3 studies | 25% ± 7% | |
| ciliated cell | 3 studies | 18% ± 1% | |
| smooth muscle cell | 3 studies | 17% ± 1% | |
| pericyte | 3 studies | 17% ± 1% | |
| hepatocyte | 3 studies | 41% ± 31% |
